2008 annual financial data
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) 2008 Operating margin
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) 2008 operating margin…
Direct answer
Operating margin was 33.95%.
Operating income was 15,786,766 USD and net income was 8,010,223 USD.
Operating cash flow was 10,504,836 USD.
Get free Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 46,496,904 USD
- Operating income
- 15,786,766 USD
- Net income
- 8,010,223 USD
- Operating cash flow
- 10,504,836 USD
Explore related company data
View all 2008 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) financial years